| Members |
targetComponentId |
| Loperamide hydrochloride+simethicone |
Product containing loperamide and simeticone (medicinal product) |
| Lophortyx gambelii |
Callipepla gambelii (organism) |
| Loracarbef 100mg/5mL oral suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef 100mg/5mL suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef 200mg/5mL oral suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef 200mg/5mL suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef, anhydrous 100mg/5mL powder |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef, anhydrous 200mg/5 mL powder |
Loracarbef 40 mg/mL oral suspension |
| Loratadine 10mg/10mL syrup |
Loratadine 1 mg/mL oral solution |
| Loratadine+pseudoephedrine sulfate 5mg/120mg m/r tablet |
Loratadine and pseudoephedrine only product in oral dose form |
| Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet |
Loratadine and pseudoephedrine only product in oral dose form |
| Lordosis in hip disease |
Lordosis deformity of spine due to disorder of hip region |
| Lordosis in skeletal dysplasia |
Lordosis deformity of spine due to congenital skeletal dysplasia |
| Lovastatin 10mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 10mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 20mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 20mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 40mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 40mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 60mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 60mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Low cervical cesarean section |
Lower uterine segment caesarean section |
| Low cervical cesarean section |
Lower uterine segment caesarean section |
| Low income benefits NOS |
Low income benefits |
| Low income benefits NOS |
Low income benefits |
| Low-grade neuroendocrine neoplasm of corpus uteri |
Well-differentiated neuroendocrine tumor of corpus uteri (disorder) |
| Lower abdomen soft tissue X-ray |
Plain X-ray of soft tissue of lower abdomen (procedure) |
| Lower abdomen soft tissue X-ray NOS |
Plain X-ray of soft tissue of lower abdomen (procedure) |
| Lower abdomen soft tissue X-ray NOS |
Plain X-ray of soft tissue of lower abdomen (procedure) |
| Lower extremity or both lower extremities |
Lower limb structure |
| Lower leg flap |
Flap (substance) |
| Lower leg random pattern flap |
Random pattern flap |
| Lower limb flap |
Flap (substance) |
| Lower limb vascular access incision |
Incision |
| Lower urinary tract calculus NOS |
Calculus of lower urinary tract |
| Lower urinary tract calculus NOS |
Calculus of lower urinary tract |
| Lower uterine segment cesarean delivery NEC |
Lower uterine segment caesarean section |
| Lubricant substance |
Automotive lubricant |
| Lubricating oil |
Automotive lubricating oil (substance) |
| Lucilia sericata |
Phaenicia sericata |
| Lumbar discography |
Discography with injection of contrast into intervertebral disc of lumbar spine (procedure) |
| Lumbar puncture as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at the time of procedure |
Complication of procedure |
| Lumbar somatic dysfunction |
Somatic dysfunction of lumbar region (finding) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine X-ray |
Plain X-ray of lumbar spine |
| Lumbar spine dual energy X-ray photon absorptiometry scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine dual energy X-ray photon absorptiometry scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine operations NOS |
Surgical procedure on lumbar spine (procedure) |
| Lumbosacral neuritis, unspecified |
Lumbosacral radiculitis |
| Lump, breast - NOS |
Breast lump |
| Lump, breast - NOS |
Breast lump |
| Lung TNM finding |
American Joint Committee on Cancer allowable value |
| Lung collapse prevention NOS |
Lung collapse prevention |
| Lung collapse prevention NOS |
Lung collapse prevention |
| Lung collapse production NOS |
Therapeutic pneumothorax |
| Lung collapse production NOS |
Therapeutic pneumothorax |
| Lung disease due to external agents NOS |
Lung disease due to external agents (disorder) |
| Lung disease due to external agents NOS |
Lung disease due to external agents (disorder) |
| Lung empyema NOS |
Empyema of pleura |
| Lung function test NOS |
Measurement of respiratory function |
| Lung function test NOS |
Measurement of respiratory function |
| Lung volume testing NOS |
Lung volume test |
| Lung volume testing NOS |
Lung volume test |
| Lupus erythematosus (LE) cells NOS |
L.E. cell preparation |
| Lupus erythematosus NOS |
Lupus erythematosus |
| Lupus erythematosus cell |
Lupus erythematosus cell |
| Luteinizing hormone releasing factor |
Gonadotropin releasing factor |
| Luteinizing hormone releasing factor preparation |
Product containing gonadotropin releasing factor (product) |
| Lutropin alfa 75iu injection (pdr for recon)+solvent |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Lutropin alfa 75iu injection (pdr for recon)+solvent |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Lymphadenitis NOS |
Lymphadenitis |
| Lymphadenitis NOS |
Lymphadenitis |
| Lymphadenoid goiter |
Hashimoto thyroiditis |
| Lymphadenopathy-associated virus, type II (LAV-II) |
Human immunodeficiency virus 2 (organism) |
| Lymphangiogram |
Fluoroscopic lymphangiography with contrast (procedure) |
| Lymphangiogram follow through |
Fluoroscopic lymphangiography with contrast (procedure) |
| Lymphangiogram of upper extremity |
Fluoroscopic lymphangiography of upper limb with contrast (procedure) |
| Lymphangiography NOS |
Fluoroscopic lymphangiography with contrast (procedure) |
| Lymphangiography NOS |
Fluoroscopic lymphangiography with contrast (procedure) |
| Lymphangiography abnormal |
Fluoroscopic lymphangiography with contrast abnormal |
| Lymphangiography abnormal |
Fluoroscopic lymphangiography with contrast abnormal |
| Lymphangiography normal |
Fluoroscopic lymphangiography with contrast normal (finding) |
| Lymphangiography normal |
Fluoroscopic lymphangiography with contrast normal (finding) |
| Lymphangiography of left half of abdomen |
Fluoroscopic lymphangiography of left half of abdomen with contrast (procedure) |
| Lymphangiography of left half of pelvis |
Fluoroscopic lymphangiography of left half of pelvis with contrast (procedure) |
| Lymphangiography of left lower limb |
Fluoroscopic lymphangiography of left lower limb with contrast (procedure) |
| Lymphangiography of left upper limb |
Fluoroscopic lymphangiography of left upper limb with contrast |
| Lymphangiography of lower extremity |
Fluoroscopic lymphangiography of lower limb with contrast (procedure) |
| Lymphangiography of mediastinal lymph nodes |
Fluoroscopic lymphangiography of mediastinal lymph node group with contrast (procedure) |
| Lymphangiography of mediastinal lymph nodes |
Fluoroscopic lymphangiography of mediastinal lymph node group with contrast (procedure) |
| Lymphangiography of para-aortic lymph nodes |
Fluoroscopic lymphangiography of para-aortic lymph node group with contrast (procedure) |
| Lymphangiography of para-aortic lymph nodes |
Fluoroscopic lymphangiography of para-aortic lymph node group with contrast (procedure) |
| Lymphangiography of right half of abdomen |
Fluoroscopic lymphangiography of right half of abdomen with contrast (procedure) |
| Lymphangiography of right half of pelvis |
Fluoroscopic lymphangiography of right half of pelvis with contrast (procedure) |
| Lymphangiography of right lower limb |
Fluoroscopic lymphangiography of right lower limb with contrast (procedure) |
| Lymphangiography of right upper limb |
Fluoroscopic lymphangiography of right upper limb with contrast |
| Lymphangiography of upper extremities, bilateral |
Fluoroscopic lymphangiography of bilateral upper limbs with contrast (procedure) |
| Lymphangioma, no International Classification of Diseases for Oncology subtype |
Benign lymphangioma |
FHIR